Related Experiment Video
Updated: Jun 23, 2025
An Electrochemiluminescence-Based Assay for MeCP2 Protein Variants
Published on: May 22, 2020
An Irak1-Mecp2 tandem duplication mouse model for the study of MECP2 duplication syndrome
Eleonora Maino1,2, Ori Scott1,3, Samar Z Rizvi1,2
1Program in Genetics and Genome Biology, the Hospital for Sick Children, Toronto, ON M5G 0A4, Canada.
Abstract:
MECP2 duplication syndrome (MDS) is a neurodevelopmental disorder caused by tandem duplication of the MECP2 locus and its surrounding genes, including IRAK1. Current MDS mouse models involve transgenic expression of MECP2 only, limiting their applicability to the study of the disease. Herein, we show that an efficient and precise CRISPR/Cas9 fusion proximity-based approach can be utilized to generate an Irak1-Mecp2 tandem duplication mouse model ('Mecp2 Dup'). The Mecp2 Dup mouse model recapitulates the genomic landscape of human MDS by harboring a 160 kb tandem duplication encompassing Mecp2 and Irak1, representing the minimal disease-causing duplication, and the neighboring genes Opn1mw and Tex28. The Mecp2 Dup model exhibits neuro-behavioral abnormalities, and an abnormal immune response to infection not previously observed in other mouse models, possibly owing to Irak1 overexpression. The Mecp2 Dup model thus provides a tool to investigate MDS disease mechanisms and develop potential therapies applicable to patients.
Insights
Researchers developed a new mouse model for MECP2 duplication syndrome (MDS) using CRISPR/Cas9 technology. This model accurately reflects the human genetic duplication, offering new insights into MDS neurodevelopmental and immune system abnormalities.
Area of Science:
- Genetics
- Neuroscience
- Immunology
Background:
- MECP2 duplication syndrome (MDS) is a severe neurodevelopmental disorder.
- Existing mouse models do not fully replicate the genetic duplication found in human MDS patients.
Purpose of the Study:
- To create a novel mouse model of MDS that precisely mimics the human genomic duplication.
- To investigate the neurodevelopmental and immune-related aspects of MDS using this new model.
Main Methods:
- Utilized a CRISPR/Cas9 fusion proximity-based approach for precise gene editing.
- Generated a tandem duplication encompassing Mecp2 and Irak1 genes in mice, creating the 'Mecp2 Dup' model.
Main Results:
- The 'Mecp2 Dup' mouse model successfully recapitulates the 160 kb tandem duplication found in human MDS.
- Observed neuro-behavioral abnormalities and an abnormal immune response to infection in the Mecp2 Dup mice.
- The model includes duplication of neighboring genes Opn1mw and Tex28, alongside Mecp2 and Irak1.
Conclusions:
- The Mecp2 Dup mouse model provides a more accurate representation of human MDS than previous models.
- This model is a valuable tool for studying MDS pathogenesis and exploring therapeutic strategies.
- The inclusion of Irak1 duplication may explain previously unobserved immune responses in MDS models.
